Compounds > triazoles

Page last updated: 2024-08-24

triazoles and Gonorrhea

triazoles has been researched along with Gonorrhea in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	10 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Craft, JC; Fernandes, P	1
Amrane, S; Raoult, D	1
Gandhi, MA; Mancuso, AM; Slish, J	1
Bristow, CC; Cristillo, AD; Dillon, JA; Dong, H; Grad, YH; Kirkcaldy, RD; Klausner, JD; Lawrence, K; Morris, SR; Nicholas, RA; Oldach, D; Rice, PA; Shafer, WM; Torrone, E; Wi, TE; Zhou, P	1
de Vries, HJC; Schim-van der Loeff, MF	1
Avery, A; Bradshaw, CS; Chen, MY; Das, AF; Donovan, B; Fairley, CK; Hardy, D; Hocking, JS; Howden, BP; McNulty, A; Nenninger, A; Oldach, D; Tabrizi, SN; Whiley, D	1
Lewis, DA	1
Fernandes, P; Jensen, JS; Unemo, M	1
Dixon, PB; Fernandes, P; Golden, M; Harbison, HS; Hook, EW; Jamieson, BD; Lowens, S	1
Chong, Y; Lee, H; Lee, K	1

Reviews

3 review(s) available for triazoles and Gonorrhea

Article	Year
Solithromycin (CEM-101): A New Fluoroketolide Antibiotic and Its Role in the Treatment of Gonorrhea. Journal of pharmacy practice, 2018, Volume: 31, Issue:2 Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Bacterial; Gonorrhea; Humans; Macrolides; Treatment Outcome; Triazoles	2018
New treatment options for Neisseria gonorrhoeae in the era of emerging antimicrobial resistance. Sexual health, 2019, Volume: 16, Issue:5 Topics: Acenaphthenes; Anti-Bacterial Agents; Barbiturates; Drug Development; Drug Resistance, Multiple, Bacterial; Gonorrhea; Heterocyclic Compounds, 3-Ring; Humans; Isoxazoles; Macrolides; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds; Triazoles	2019
New treatment options for infections caused by increasingly antimicrobial-resistant Neisseria gonorrhoeae. Expert review of anti-infective therapy, 2016, Volume: 14, Issue:2 Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Drug Resistance, Bacterial; Drug Therapy, Combination; Gonorrhea; Humans; Isoxazoles; Macrolides; Morpholines; Neisseria gonorrhoeae; Neisseriaceae Infections; Oxazolidinones; Pharyngitis; Spectinomycin; Spiro Compounds; Triazoles	2016

Trials

3 trial(s) available for triazoles and Gonorrhea

Article	Year
Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting. Sexually transmitted diseases, 2019, Volume: 46, Issue:3 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Vaccines; Barbiturates; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Gonorrhea; Group Processes; Humans; Isoxazoles; Macrolides; Microbial Sensitivity Tests; Morpholines; Mutation; Neisseria gonorrhoeae; Oxazolidinones; Public Health; Sexually Transmitted Diseases; Spiro Compounds; Topoisomerase Inhibitors; Triazoles; World Health Organization	2019
Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial. The Lancet. Infectious diseases, 2019, Volume: 19, Issue:8 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Female; Gonorrhea; Humans; Injections, Intramuscular; Macrolides; Male; Neisseria gonorrhoeae; Treatment Outcome; Triazoles; United States	2019
A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Oct-01, Volume: 61, Issue:7 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Macrolides; Male; Middle Aged; Neisseria gonorrhoeae; Triazoles; Young Adult	2015

Other Studies

4 other study(ies) available for triazoles and Gonorrhea

Article	Year
Phase 3 trial of treating gonorrhoea with solithromycin. The Lancet. Infectious diseases, 2019, Volume: 19, Issue:9 Topics: Azithromycin; Ceftriaxone; Genitalia; Gonorrhea; Humans; Macrolides; Triazoles	2019
Should we fear gonorrhoea? The Lancet. Infectious diseases, 2019, Volume: 19, Issue:12 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Gonorrhea; Humans; Macrolides; Neisseria gonorrhoeae; Triazoles	2019
Solithromycin for the treatment of drug-resistant gonorrhoea. The Lancet. Infectious diseases, 2019, Volume: 19, Issue:8 Topics: Azithromycin; Ceftriaxone; Genitalia; Gonorrhea; Humans; Macrolides; Triazoles	2019
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6 Topics: Anti-Bacterial Agents; Azithromycin; DNA, Bacterial; DNA, Ribosomal; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycoplasma genitalium; Mycoplasma Infections; Neisseria gonorrhoeae; Triazoles	2014